BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 15093921)

  • 1. Loss of biological effect in prolonged fraction delivery.
    Fowler JF; Welsh JS; Howard SP
    Int J Radiat Oncol Biol Phys; 2004 May; 59(1):242-9. PubMed ID: 15093921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The kinetics of repair of sublethal radiation-induced damage in pig skin: studies with multiple interfraction intervals.
    van den Aardweg GJ; Hopewell JW; Guttenberger R
    Radiat Res; 1996 May; 145(5):586-94. PubMed ID: 8619024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of very low dose-rate (90)Sr/(90)Y exposure on the acute moist desquamation response of pig skin.
    Millar WT; Hopewell JW
    Radiother Oncol; 2007 May; 83(2):187-95. PubMed ID: 17467835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in tumor cell response due to prolonged dose delivery times in fractionated radiation therapy.
    Paganetti H
    Int J Radiat Oncol Biol Phys; 2005 Nov; 63(3):892-900. PubMed ID: 16199319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A test of equal effect per fraction in the kidney of the mouse.
    Joiner MC; Rojas A; Johns H
    Radiat Res; 1992 May; 130(2):227-35. PubMed ID: 1574579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro determination of radiation sensitivity parameters for DU-145 prostate cancer cells.
    Wang JZ; Rhee JG; Shi P; Stewart RD; Allen Li X
    Int J Radiat Biol; 2008 Jun; 84(6):515-22. PubMed ID: 18470750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Repair rate in mouse lung after clinically relevant radiation doses per fraction.
    van Rongen E; Travis EL; Thames HD
    Radiat Res; 1995 Jan; 141(1):74-8. PubMed ID: 7997517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recovery from sublethal damage during intermittent exposures in cultured tumor cells: implications for dose modification in radiosurgery and IMRT.
    Shibamoto Y; Ito M; Sugie C; Ogino H; Hara M
    Int J Radiat Oncol Biol Phys; 2004 Aug; 59(5):1484-90. PubMed ID: 15275736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modelling carcinogenesis after radiotherapy using Poisson statistics: implications for IMRT, protons and ions.
    Jones B
    J Radiol Prot; 2009 Jun; 29(2A):A143-57. PubMed ID: 19454805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dosimetry and radiobiologic model comparison of IMRT and 3D conformal radiotherapy in treatment of carcinoma of the prostate.
    Luxton G; Hancock SL; Boyer AL
    Int J Radiat Oncol Biol Phys; 2004 May; 59(1):267-84. PubMed ID: 15093924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-dose-rate brachytherapy is superior to high-dose-rate brachytherapy for bladder cancer.
    Pos FJ; Horenblas S; Lebesque J; Moonen L; Schneider C; Sminia P; Bartelink H
    Int J Radiat Oncol Biol Phys; 2004 Jul; 59(3):696-705. PubMed ID: 15183473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Repair in mouse lung between multiple small doses of X rays.
    Travis EL; Parkins CS; Down JD; Fowler JF; Thames HD
    Radiat Res; 1983 May; 94(2):326-39. PubMed ID: 6856778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimization of the temporal pattern of radiation: an IMRT based study.
    Altman MB; Chmura SJ; Deasy JO; Roeske JC
    Int J Radiat Oncol Biol Phys; 2006 Nov; 66(3):898-905. PubMed ID: 17011463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Application of the linear-quadratic model to radioimmunotherapy: further support for the advantage of longer-lived radionuclides.
    Howell RW; Goddu SM; Rao DV
    J Nucl Med; 1994 Nov; 35(11):1861-9. PubMed ID: 7965170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proposal of human spinal cord reirradiation dose based on collection of data from 40 patients.
    Nieder C; Grosu AL; Andratschke NH; Molls M
    Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):851-5. PubMed ID: 15708265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dose rate dependence of the relative biological effectiveness of 103Pd for continuous low dose rate irradiation of BA1112 rhabdomyosarcoma cells in vitro relative to acute exposures.
    Nath R; Bongiorni P; Chen Z; Gragnano J; Rockwell S
    Int J Radiat Biol; 2005 Sep; 81(9):689-99. PubMed ID: 16368647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity.
    Akimoto T; Ito K; Saitoh J; Noda SE; Harashima K; Sakurai H; Nakayama Y; Yamamoto T; Suzuki K; Nakano T; Niibe H
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):463-71. PubMed ID: 16168838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiobiological investigation of dose-rate effects in intensity-modulated radiation therapy.
    Sterzing F; Münter MW; Schäfer M; Haering P; Rhein B; Thilmann C; Debus J
    Strahlenther Onkol; 2005 Jan; 181(1):42-8. PubMed ID: 15660192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
    EFSA GMO Panel Working Group on Animal Feeding Trials
    Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Further radiobiologic modeling of palliative radiotherapy: use of virtual trials.
    Jones B; Dale RG
    Int J Radiat Oncol Biol Phys; 2007 Sep; 69(1):221-9. PubMed ID: 17707276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.